Concepedia

Andrew Higham

AH

40

Publications

9.7K

Citations

27

H-Index

1998

Active since

Affiliations

Medicines Evaluation Unit(Current)

Manchester Academic Health Science Centre

Manchester University NHS Foundation Trust

University of Manchester

Imperial College London

Andrew Higham is an author at Medicines Evaluation Unit specializing in medicine, immunology, and pulmonary disease.

ORCID

Top concepts

Publications per year

1998–2024

40

Publications

40

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

M R Stearne, S L Palmer, M S Hammersley et al. · 1998 · 4.8K citations

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

M R Stearne, S L Palmer, M S Hammersley et al. · 1998 · 1.4K citations

, , +16

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

, , +7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

, , +3

Rows per page

1–5 of 40